We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

110 hedge funds and large institutions have $110M invested in Antares Pharma, Inc. in 2017 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 36 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 13

7% more funds holding

Funds holding: 103 → 110 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 36

37% less capital invested

Capital invested by funds: $176M → $110M (-$65.4M)

59% less call options, than puts

Call options by funds: $46K | Put options by funds: $112K

Holders
110
Holders Change
+7
Holders Change %
+6.8%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
29
Reduced
36
Closed
13
Calls
$46K
Puts
$112K
Net Calls
-$66K
Net Calls Change
-$43K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$7.4M
2
BC
Broadfin Capital
New York
+$2.89M
3
PAM
Panagora Asset Management
Massachusetts
+$1.09M
4
TF
TIAA FSB
Florida
+$1.07M
5
Wells Fargo
Wells Fargo
California
+$556K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$4.75M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.48M
3
PA
Perceptive Advisors
New York
-$1.32M
4
RCMNY
Rubric Capital Management (New York)
New York
-$1.05M
5
Deutsche Bank
Deutsche Bank
Germany
-$913K
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$512K – – –
PCM
27
Perkins Capital Management
Minnesota
$501K -$248K -114,000 -31%
GCP
28
GSA Capital Partners
United Kingdom
$455K +$101K +46,425 +25%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$454K -$683 -314 -0.1%
ARTA
30
A.R.T. Advisors
New York
$377K +$382K +175,613 +1,253%
RJFSA
31
Raymond James Financial Services Advisors
Florida
$360K +$102K +46,766 +35%
AQR Capital Management
32
AQR Capital Management
Connecticut
$342K +$53.9K +24,745 +17%
Baird Financial Group
33
Baird Financial Group
Wisconsin
$341K -$39.2K -18,000 -10%
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$282K +$44.2K +20,300 +17%
MCM
35
Moore Capital Management
New York
$279K -$131K -60,000 -30%
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$275K +$301K +138,383 New
M&T Bank
37
M&T Bank
New York
$259K – – –
Goldman Sachs
38
Goldman Sachs
New York
$257K -$446K -205,037 -61%
CIBC Private Wealth Group
39
CIBC Private Wealth Group
Georgia
$249K – – –
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$248K -$55.9K -25,672 -17%
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$237K -$2.3K -1,057 -0.9%
AG
42
Advisor Group
Arizona
$203K +$221K +101,337 +20,267%
BP
43
Ballentine Partners
Massachusetts
$199K – – –
PNC Financial Services Group
44
PNC Financial Services Group
Pennsylvania
$199K – – –
V
45
Veritable
Delaware
$199K – – –
AIG
46
American International Group
New York
$193K +$997 +458 +0.5%
Principal Financial Group
47
Principal Financial Group
Iowa
$152K +$113K +51,866 +209%
JP Morgan Chase
48
JP Morgan Chase
New York
$141K +$154K +70,810 New
VOYA Investment Management
49
VOYA Investment Management
Georgia
$129K – – –
Two Sigma Advisers
50
Two Sigma Advisers
New York
$120K +$9K +4,134 +7%
1
2
3 4 5

ATRS Hedge Fund Activity: Q4 2017 in Review

110 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q4 2017, worth a combined $110M — down 37% from $176M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ATRS positions and 13 closed out — a net gain of 8 holders — while 29 added to existing stakes and 36 trimmed.

The largest buyer was Armistice Capital, adding an estimated $7.4M. The largest seller was Renaissance Technologies, cutting an estimated $4.75M.

  • 110 institutional investors held Antares Pharma, Inc. (ATRS) as of Q4 2017, up from 103 in Q3 2017.
  • Funds reported $110M of Antares Pharma, Inc. stock for Q4 2017, down 37% quarter-over-quarter.
  • 21 funds opened new Antares Pharma, Inc. positions in Q4 2017 and 13 closed out, a net change of +8 holders.
  • The largest Antares Pharma, Inc. buyer in Q4 2017 was Armistice Capital, an estimated $7.4M added.
  • The largest Antares Pharma, Inc. seller in Q4 2017 was Renaissance Technologies, an estimated $4.75M sold.

Based on aggregated 13F filings for Q4 2017.